Cargando…
Basic Mechanisms of JAK Inhibition
Autores principales: | Lin, Chung MA, Cooles, Faye AH, Isaacs, John D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361186/ https://www.ncbi.nlm.nih.gov/pubmed/32676567 http://dx.doi.org/10.31138/mjr.31.1.100 |
Ejemplares similares
-
The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy
por: Cooles, Faye A.H., et al.
Publicado: (2018) -
The infection risks of JAK inhibition
por: Adas, Maryam A., et al.
Publicado: (2021) -
Myelofibrosis in 2019: moving beyond JAK2 inhibition
por: Schieber, Michael, et al.
Publicado: (2019) -
Immune reconstitution 20 years after treatment with alemtuzumab in a rheumatoid arthritis cohort: implications for lymphocyte depleting therapies
por: Cooles, Faye A. H., et al.
Publicado: (2016) -
Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis
por: Cooles, Faye A. H., et al.
Publicado: (2018)